1
|
Mohamed N, Juan MRS, Navarathna DH. Multifocal pneumonia caused by Bordetella bronchiseptica: Insights from a human case study. IDCases 2024; 37:e02030. [PMID: 39129825 PMCID: PMC11315158 DOI: 10.1016/j.idcr.2024.e02030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2024] [Revised: 07/10/2024] [Accepted: 07/14/2024] [Indexed: 08/13/2024] Open
Abstract
This case report describes a 43-year-old man who presented with respiratory distress and was diagnosed with an exacerbation of congestive heart failure and multifocal pneumonia caused by Bordetella bronchiseptica. Microbiological work up of a respiratory sample identified the causative organism, prompting antibiotic treatment and recommending vaccination for his dog. This case emphasizes the need to consider diverse origins in respiratory infections for effective clinical management.
Collapse
Affiliation(s)
- Nada Mohamed
- Department of Pathology and Laboratory Medicine, Baylor Scott & White Medical Center, Temple, TX, USA
| | - Ma Rowena San Juan
- Department of Pathology and Laboratory Medicine Services, Central Texas Veterans Health Care System, Temple, TX, USA
| | - Dhammika H. Navarathna
- Department of Pathology and Laboratory Medicine Services, Central Texas Veterans Health Care System, Temple, TX, USA
| |
Collapse
|
2
|
Belhart K, Sisti F, Gestal MC, Fernández J. Bordetella bronchiseptica diguanylate cyclase BdcB inhibits the type three secretion system and impacts the immune response. Sci Rep 2023; 13:7157. [PMID: 37130958 PMCID: PMC10154355 DOI: 10.1038/s41598-023-34106-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2022] [Accepted: 04/24/2023] [Indexed: 05/04/2023] Open
Abstract
Bordetella bronchiseptica is a gram-negative bacterium that causes respiratory diseases in different animals, including mice, making B. bronchiseptica the gold-standard model to investigate host-pathogen interaction at the molecular level. B. bronchiseptica utilizes many different mechanisms to precisely regulate the expression of virulence factors. Cyclic di-GMP is a second messenger synthesized by diguanylate cyclases and degraded by phosphodiesterases that regulates the expression of multiple virulence factors including biofilm formation. As in other bacteria, we have previously shown that c-di-GMP regulates motility and biofilm formation in B. bronchiseptica. This work describes the diguanylate cyclase BdcB (Bordetella diguanylate cyclase B) as an active diguanylate cyclase that promotes biofilm formation and inhibits motility in B. bronchiseptica. The absence of BdcB increased macrophage cytotoxicity in vitro and induced a greater production of TNF-α, IL-6, and IL-10 by macrophages. Our study reveals that BdcB regulates the expression of components of T3SS, an important virulence factor of B. bronchiseptica. The Bb∆bdcB mutant presented increased expression of T3SS-mediated toxins such as bteA, responsible for cytotoxicity. Our in vivo results revealed that albeit the absence of bdcB did not affect the ability of B. bronchiseptica to infect and colonize the respiratory tract of mice, mice infected with Bb∆bdcB presented a significantly higher pro-inflammatory response than those infected with wild type B. bronchiseptica.
Collapse
Affiliation(s)
- Keila Belhart
- Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Instituto de Biotecnología y Biología Molecular (IBBM)-CCT-CONICET-La Plata, Universidad Nacional de La Plata, La Plata, Argentina
| | - Federico Sisti
- Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Instituto de Biotecnología y Biología Molecular (IBBM)-CCT-CONICET-La Plata, Universidad Nacional de La Plata, La Plata, Argentina
| | - Mónica C Gestal
- Department of Microbiology and Immunology, Louisiana State University (LSU) Health Sciences Center at Shreveport, Shreveport, LA, USA.
| | - Julieta Fernández
- Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Instituto de Biotecnología y Biología Molecular (IBBM)-CCT-CONICET-La Plata, Universidad Nacional de La Plata, La Plata, Argentina.
| |
Collapse
|
3
|
Holban AM, Gregoire CM, Gestal MC. Conquering the host: Bordetella spp. and Pseudomonas aeruginosa molecular regulators in lung infection. Front Microbiol 2022; 13:983149. [PMID: 36225372 PMCID: PMC9549215 DOI: 10.3389/fmicb.2022.983149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Accepted: 08/17/2022] [Indexed: 11/27/2022] Open
Abstract
When bacteria sense cues from the host environment, stress responses are activated. Two component systems, sigma factors, small RNAs, ppGpp stringent response, and chaperones start coordinate the expression of virulence factors or immunomodulators to allow bacteria to respond. Although, some of these are well studied, such as the two-component systems, the contribution of other regulators, such as sigma factors or ppGpp, is increasingly gaining attention. Pseudomonas aeruginosa is the gold standard pathogen for studying the molecular mechanisms to sense and respond to environmental cues. Bordetella spp., on the other hand, is a microbial model for studying host-pathogen interactions at the molecular level. These two pathogens have the ability to colonize the lungs of patients with chronic diseases, suggesting that they have the potential to share a niche and interact. However, the molecular networks that facilitate adaptation of Bordetella spp. to cues are unclear. Here, we offer a side-by-side comparison of what is known about these diverse molecular mechanisms that bacteria utilize to counteract host immune responses, while highlighting the relatively unexplored interactions between them.
Collapse
Affiliation(s)
- Alina M. Holban
- Research Institute of the University of Bucharest (ICUB), Bucharest, Romania
- Department of Microbiology and Immunology, Faculty of Biology, University of Bucharest, Bucharest, Romania
| | - Courtney M. Gregoire
- Department of Microbiology and Immunology, Louisiana State University Health Science Center, Shreveport, LA, United States
| | - Monica C. Gestal
- Department of Microbiology and Immunology, Louisiana State University Health Science Center, Shreveport, LA, United States
- *Correspondence: Monica C. Gestal, ;
| |
Collapse
|
4
|
Singleton DA, Stavisky J, Jewell C, Smyth S, Brant B, Sánchez-Vizcaíno F, Dawson S, Pinchbeck GL, Noble PJM, Radford AD. Small animal disease surveillance 2019: respiratory disease, antibiotic prescription and canine infectious respiratory disease complex. Vet Rec 2020; 184:640-645. [PMID: 31123207 DOI: 10.1136/vr.l3128] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Affiliation(s)
- David A Singleton
- Institute of Infection and Global Health, University of Liverpool, Leahurst Campus, Neston CH64 7TE, UK
| | - Jenny Stavisky
- School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington Campus, Loughborough LE12 5RD, UK
| | - Christopher Jewell
- Lancaster Medical School, Lancaster University, Furness Building, Lancaster LA1 4YG, UK
| | - Steven Smyth
- Institute of Infection and Global Health, University of Liverpool, Leahurst Campus, Neston CH64 7TE, UK
| | - Bethaney Brant
- Institute of Infection and Global Health, University of Liverpool, Leahurst Campus, Neston CH64 7TE, UK
| | | | - Susan Dawson
- Institute of Veterinary Science, University of Liverpool, Leahurst Campus, Neston CH64 7TE, UK
| | - Gina L Pinchbeck
- Institute of Infection and Global Health, University of Liverpool, Leahurst Campus, Neston CH64 7TE, UK
| | - Peter J M Noble
- Institute of Veterinary Science, University of Liverpool, Leahurst Campus, Neston CH64 7TE, UK
| | - Alan D Radford
- Institute of Infection and Global Health, University of Liverpool, Leahurst Campus, Neston CH64 7TE, UK
| |
Collapse
|
5
|
Woods P, Ordemann K, Stanecki C, Brown J, Uzodi A. Bordetella bronchiseptica Pneumonia in an Adolescent: Case Report and Review of the Pediatric Literature. Clin Pediatr (Phila) 2020; 59:322-328. [PMID: 31876162 DOI: 10.1177/0009922819897355] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Pamela Woods
- Children's International Pediatric Clinic, Hammond, LA, USA
| | - Kelly Ordemann
- Our Lady of the Lake Children's Hospital, Baton Rouge, LA, USA
| | | | - Jessica Brown
- Our Lady of the Lake Children's Hospital, Baton Rouge, LA, USA
| | - Adaora Uzodi
- Our Lady of the Lake Children's Hospital, Baton Rouge, LA, USA
| |
Collapse
|
6
|
Hahn A, Burrell A, Fanous H, Chaney H, Sami I, Perez GF, Koumbourlis AC, Freishtat RJ, Crandall KA. Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity. Heliyon 2018; 4:e00795. [PMID: 30238064 PMCID: PMC6143701 DOI: 10.1016/j.heliyon.2018.e00795] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2018] [Revised: 08/30/2018] [Accepted: 09/12/2018] [Indexed: 12/22/2022] Open
Abstract
Background Cystic fibrosis (CF) is associated with significant morbidity and early mortality due to recurrent acute and chronic lung infections. The chronic use of multiple antibiotics increases the possibility of multidrug resistance (MDR). Antibiotic susceptibility determined by culture-based techniques may not fully represent the resistance profile. The study objective was to detect additional antibiotic resistance using molecular methods and relate the presence of MDR to airway microbiome diversity and pulmonary function. Methods Bacterial DNA was extracted from sputum samples and amplified for the V4 region of the 16S rRNA gene. An qPCR array was used to detect antibiotic resistance genes. Clinical culture results and pulmonary function were also noted for each encounter. Results Six study participants contributed samples from 19 encounters. Those samples with MDR (n = 7) had significantly lower diversity measured by inverse Simpson's index than those without (n = 12) (2.193 ± 0.427 vs 6.023 ± 1.564, p = 0.035). Differential abundance showed that samples with MDR had more Streptococcus (p = 0.002) and Alcaligenaceae_unclassified (p = 0.002). Pulmonary function was also decreased when MDR was present (FEV1, 51 ± 22.9 vs 77 ± 26.7, p = 0.054; FVC, 64.5 ± 22.7 vs 91.6 ± 27.7, p = 0.047). Conclusions The presence of MDR within the CF airway microbiome was associated with decreased microbial diversity, the presence of Alcaligenes, and decreased pulmonary function.
Collapse
Affiliation(s)
- Andrea Hahn
- Division of Infectious Diseases, Children's National Health System, Washington, DC, USA.,Center for Genetic Medicine Research, The Children's Research Institute, Washington, DC, USA.,Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC, USA
| | - Aszia Burrell
- Center for Genetic Medicine Research, The Children's Research Institute, Washington, DC, USA
| | - Hani Fanous
- Division of Pulmonary and Sleep Medicine, Children's National Health System, Washington, DC, USA
| | - Hollis Chaney
- Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.,Division of Pulmonary and Sleep Medicine, Children's National Health System, Washington, DC, USA
| | - Iman Sami
- Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.,Division of Pulmonary and Sleep Medicine, Children's National Health System, Washington, DC, USA
| | - Geovanny F Perez
- Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.,Division of Pulmonary and Sleep Medicine, Children's National Health System, Washington, DC, USA
| | - Anastassios C Koumbourlis
- Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.,Division of Pulmonary and Sleep Medicine, Children's National Health System, Washington, DC, USA
| | - Robert J Freishtat
- Center for Genetic Medicine Research, The Children's Research Institute, Washington, DC, USA.,Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.,Division of Emergency Medicine, Children's National Health System, Washington, DC, USA
| | - Keith A Crandall
- Computational Biology Institute, Milken Institute School of Public Health, George Washington University, Washington, DC, USA
| |
Collapse
|
7
|
Karamooz E, Yap VL, Barker AF, Metersky ML. Bordetella bronchiseptica in non-cystic fibrosis bronchiectasis. Respir Med Case Rep 2018; 25:187-188. [PMID: 30191122 PMCID: PMC6125826 DOI: 10.1016/j.rmcr.2018.08.023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2018] [Accepted: 08/27/2018] [Indexed: 10/31/2022] Open
Abstract
Bordetella bronchiseptica is a rare pulmonary infection, often associated with zoonotic transmission. It has been described in immunocompromised patients and those with underlying pulmonary disease. However, there are no case series describing the spectrum of disease caused by Bordetella bronchiseptica in patients with non-cystic fibrosis bronchiectasis. Here, we report three cases of Bordetella bronchiseptica infection in patients with non-cystic fibrosis bronchiectasis and highlight the pathophysiology of the microbe. While the clinical presentation can be quite variable, it is important to note that Bordetella bronchiseptica can be a cause of pulmonary exacerbations and can be difficult to eradicate.
Collapse
Affiliation(s)
- Elham Karamooz
- Division of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, OR 97239, USA
| | - Vanessa L Yap
- Division of Pulmonary, Critical Care and Sleep Medicine, University of Connecticut, Farmington, CT 06030, USA
| | - Alan F Barker
- Division of Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, OR 97239, USA
| | - Mark L Metersky
- Division of Pulmonary, Critical Care and Sleep Medicine, University of Connecticut, Farmington, CT 06030, USA
| |
Collapse
|
8
|
Darrah R, Bonfield T, LiPuma JJ, Litman P, Hodges CA, Jacono F, Drumm M. Cystic Fibrosis Mice Develop Spontaneous Chronic Bordetella Airway Infections. ACTA ACUST UNITED AC 2017; 3. [PMID: 30283824 PMCID: PMC6166652 DOI: 10.16966/2470-3176.128] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Chronic pulmonary disease and infection is the primary cause of morbidity and mortality in people with cystic fibrosis (CF). Though Pseudomonas aeruginosa, is most commonly found in the airways of individuals with CF, there is increasing appreciation for the diversity of the CF microbiome, including other taxa such as Bordetella. Here we describe the identification and impact of Bordetella pseudohinzii infection in CF mice, which previously have not been thought to develop spontaneous airway infections. We determined that CF mice are more susceptible to the B. pseudohinzii infections, and less able to resolve the infection than non-CF mice. Moreover, in both CF and non-CF mice, B. pseudohinzii infections lead to markedly reduced respiratory rates and a CF-specific immune response. These results establish the CF mouse model as an important tool for the study of CF-relevant infection and highlight the potential contribution of Bordetella to CF clinical pathology.
Collapse
Affiliation(s)
- R Darrah
- Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland Ohio, USA
| | - T Bonfield
- Department of Pediatrics, Case Western Reserve University, Cleveland Ohio, USA
| | - J J LiPuma
- Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA
| | - P Litman
- Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland Ohio, USA
| | - C A Hodges
- Departments of Radiology, Biomedical Engineering, and Pediatrics, Case Western Reserve University, Cleveland Ohio, USA
| | - F Jacono
- Department of Medicine, Case Western Reserve University, and Louis Stokes VA Cleveland Medical Center, USA
| | - M Drumm
- Departments of Pediatrics and Genetics Genome Sciences, Case Western Reserve University, Cleveland Ohio, USA
| |
Collapse
|
9
|
Monti M, Diano D, Allegrini F, Delmonte A, Fausti V, Cravero P, Marcantognini G, Frassineti GL. Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection. BMC Infect Dis 2017; 17:644. [PMID: 28946850 PMCID: PMC5613318 DOI: 10.1186/s12879-017-2736-7] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2017] [Accepted: 09/14/2017] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND Bordetella bronchiseptica (B.bronchiseptica) is a frequent cause of respiratory infections in animals but rarely causes serious infection in humans. We present a rare case of B. bronchiseptica pneumonia in a patient with lung cancer. CASE PRESENTATION A 52-year-old white male with non small cell lung cancer developed fever during treatment with nivolumab. A persistent productive cough and a deterioration in his clinical condition led to his hospitalization for evaluation. Bronchoscopy was performed and a diagnosis of B. bronchiseptica pneumonia was made. The infection was successfully managed by antiobiotic therapy. CONCLUSIONS B. bronchiseptica is a pathogen that can cause serious infection in humans, especially in immunocompromised or immunoincompetent individuals. In our patient it showed unusual resistance to cephalosporins and poor sensitivity to amikacin. To our knowledge this is the first case of such an infection in a lung cancer patient undergoing treatment with nivolumab. When B. bronchiseptica is identified, the possibility of a nosocomial transmission must be considered.
Collapse
Affiliation(s)
- Manlio Monti
- Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
| | - Danila Diano
- Radiology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
| | - Francesco Allegrini
- Department of Infectious Diseases, Morgagni-Pierantoni Hospital, Forlì, Italy
| | - Angelo Delmonte
- Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
| | - Valentina Fausti
- Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
| | - Paola Cravero
- Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
| | - Giulia Marcantognini
- Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
| | - Giovanni Luca Frassineti
- Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
| |
Collapse
|
10
|
Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa. PLoS One 2017; 12:e0173022. [PMID: 28282386 PMCID: PMC5345789 DOI: 10.1371/journal.pone.0173022] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2016] [Accepted: 02/14/2017] [Indexed: 11/20/2022] Open
Abstract
Cystic fibrosis (CF) lungs harbor a complex community of interacting microbes, including pathogens like Pseudomonas aeruginosa. Meta-taxogenomic analysis based on V5-V6 rrs PCR products of 52 P. aeruginosa-positive (Pp) and 52 P. aeruginosa-negative (Pn) pooled DNA extracts from CF sputa suggested positive associations between P. aeruginosa and Stenotrophomonas and Prevotella, but negative ones with Haemophilus, Neisseria and Burkholderia. Internal Transcribed Spacer analyses (RISA) from individual DNA extracts identified three significant genetic structures within the CF cohorts, and indicated an impact of P. aeruginosa. RISA clusters Ip and IIIp contained CF sputa with a P. aeruginosa prevalence above 93%, and of 24.2% in cluster IIp. Clusters Ip and IIIp showed lower RISA genetic diversity and richness than IIp. Highly similar cluster IIp RISA profiles were obtained from two patients harboring isolates of a same P. aeruginosa clone, suggesting convergent evolution in the structure of their microbiota. CF patients of cluster IIp had received significantly less antibiotics than patients of clusters Ip and IIIp but harbored the most resistant P. aeruginosa strains. Patients of cluster IIIp were older than those of Ip. The effects of P. aeruginosa on the RISA structures could not be fully dissociated from the above two confounding factors but several trends in these datasets support the conclusion of a strong incidence of P. aeruginosa on the genetic structure of CF lung microbiota.
Collapse
|
11
|
Register KB, Nicholson TL, Brunelle BW. Comparison of ribotyping and sequence-based typing for discriminating among isolates of Bordetella bronchiseptica. J Microbiol Methods 2016; 129:117-126. [PMID: 27542997 DOI: 10.1016/j.mimet.2016.08.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2016] [Revised: 08/15/2016] [Accepted: 08/15/2016] [Indexed: 11/16/2022]
Abstract
PvuII ribotyping and MLST are each highly discriminatory methods for genotyping Bordetella bronchiseptica, but a direct comparison between these approaches has not been undertaken. The goal of this study was to directly compare the discriminatory power of PvuII ribotyping and MLST, using a single set of geographically and genetically diverse strains, and to determine whether subtyping based on repeat region sequences of the pertactin gene (prn) provides additional resolution. One hundred twenty-two isolates were analyzed, representing 11 mammalian or avian hosts, sourced from the United States, Europe, Israel and Australia. Thirty-two ribotype patterns were identified; one isolate could not be typed. In comparison, all isolates were typeable by MLST and a total of 30 sequence types was identified. An analysis based on Simpson's Index of Diversity (SID) revealed that ribotyping and MLST are nearly equally discriminatory, with SIDs of 0.920 for ribotyping and 0.919 for MLST. Nonetheless, for ten ribotypes and eight MLST sequence types, the alternative method discriminates among isolates that otherwise type identically. Pairing prn repeat region typing with ribotyping yielded 54 genotypes and increased the SID to 0.954. Repeat region typing combined with MLST resulted in 47 genotypes and an SID of 0.944. Given the technical and practical advantages of MLST over ribotyping, and the nominal difference in their SIDs, we conclude MLST is the preferred primary typing tool. We recommend the combination of MLST and prn repeat region typing as a high-resolution, objective and standardized approach valuable for investigating the population structure and epidemiology of B. bronchiseptica.
Collapse
Affiliation(s)
- Karen B Register
- Ruminant Diseases and Immunology Research Unit, USDA/Agricultural Research Service/National Animal Disease Center, 1920 Dayton Avenue, Ames, IA 50010, United States.
| | - Tracy L Nicholson
- Virus and Prion Research Unit, USDA/Agricultural Research Service/National Animal Disease Center, 1920 Dayton Avenue, Ames, IA 50010, United States
| | - Brian W Brunelle
- Food Safety and Enteric Pathogens Research Unit, USDA/Agricultural Research Service/National Animal Disease Center, 1920 Dayton Avenue, Ames, IA 50010, United States
| |
Collapse
|
12
|
Rampelotto RF, Hörner A, Hörner C, Righi R, Hörner R. Pneumonia caused by Bordetella bronchiseptica in two HIV-positive patients. SAO PAULO MED J 2016; 134:268-72. [PMID: 27191248 PMCID: PMC10496598 DOI: 10.1590/1516-3180.2015.02492701] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/22/2016] [Revised: 12/02/2015] [Accepted: 01/27/2016] [Indexed: 11/22/2022] Open
Abstract
CONTEXT AND OBJECTIVE Bordetella bronchiseptica (BB) is a Gram-negative coccobacillus responsible for respiratory diseases in dogs, cats and rabbits. Reports on its development in humans are rare. However, in immunosuppressed patients, especially in those with the immunodeficiency virus (HIV), BB can cause severe pulmonary infections. We report on two cases of pneumonia caused by BB in HIV-positive male patients in a university hospital. CASE REPORT The first case comprised a 43-year-old patient who was admitted presenting chronic leg pain and coughing, with suspected pneumonia. BB was isolated from sputum culture and was successfully treated with trimethoprim/sulfamethoxazole in association with levofloxacin. The second case comprised a 49-year-old patient who was admitted presenting fever, nausea, sweating and a dry cough, also with suspected pneumonia. BB was isolated from sputum culture, tracheal secretions and bronchoalveolar lavage. The disease was treated with ciprofloxacin but the patient died. CONCLUSION BB should be included in the etiology of pneumonia in immunodeficient HIV patients. As far as we know, these two were the first cases of pneumonia due to BB to occur in this university hospital.
Collapse
Affiliation(s)
- Roberta Filipini Rampelotto
- MSc. Doctoral Student, Postgraduate Pharmaceutical Sciences Program, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil.
| | - Andreas Hörner
- Undergraduate Student, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil.
| | - Christine Hörner
- Undergraduate Student, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil.
| | - Roselene Righi
- MSc. Pharmacist, Bacteriology Laboratory, Hospital Universitário de Santa Maria (HUSM), Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil.
| | - Rosmari Hörner
- PhD. Associate Professor, Department of Clinical and Toxicological Analyses, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brazil.
| |
Collapse
|
13
|
Taha-Abdelaziz K, Bassel LL, Harness ML, Clark ME, Register KB, Caswell JL. Cilia-associated bacteria in fatal Bordetella bronchiseptica pneumonia of dogs and cats. J Vet Diagn Invest 2016; 28:369-76. [PMID: 27178716 DOI: 10.1177/1040638716646806] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Bordetella bronchiseptica frequently causes nonfatal tracheobronchitis, but its role in fatal pneumonia is less recognized. Our study evaluated histologic identification of cilia-associated bacteria as a method for diagnosis of B. bronchiseptica pneumonia. Cases of fatal bronchopneumonia were studied retrospectively, excluding neonates and cases of aspiration pneumonia, minor lung lesions, or autolysis. The study population comprised 36 canine and 31 feline cases of bronchopneumonia. B. bronchiseptica was identified in 8 of 36 canine and 14 of 31 feline cases based on immunohistochemistry (IHC) using serum from a rabbit hyperimmunized with pertactin, PCR testing (Fla2/Fla12), and/or bacterial culture data when available. Of these, IHC was positive in 4 canine and 7 feline cases, PCR was positive in 8 canine and 14 feline cases, and B. bronchiseptica was isolated in 2 of 5 canine and 3 of 9 feline cases tested. Examination of histologic sections stained with hematoxylin and eosin revealed bronchial cilia-associated bacteria in 4 of 36 canine and 5 of 31 feline cases; these were all positive by IHC and PCR. The presence of cilia-associated bacteria had been noted in the pathology report for only 2 of these 9 cases. Thus, the presence of cilia-associated bacteria seems frequently overlooked by pathologists, but is a diagnostically significant feature of B. bronchiseptica pneumonia. A specific diagnosis of B. bronchiseptica pneumonia is important because it suggests primary or opportunistic bacterial pneumonia rather than aspiration pneumonia, and because of the risk of animal-to-animal transmission of B. bronchiseptica, the availability of vaccines for disease prevention, and the potential zoonotic risk to immunocompromised pet owners.
Collapse
Affiliation(s)
- Khaled Taha-Abdelaziz
- Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada (Taha-Abdelaziz, Bassel, Harness, Clark, Caswell)Department of Pathology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt (Taha-Abdelaziz)U.S. Department of Agriculture, National Animal Disease Center, Ames, IA (Register)
| | - Laura L Bassel
- Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada (Taha-Abdelaziz, Bassel, Harness, Clark, Caswell)Department of Pathology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt (Taha-Abdelaziz)U.S. Department of Agriculture, National Animal Disease Center, Ames, IA (Register)
| | - Melanie L Harness
- Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada (Taha-Abdelaziz, Bassel, Harness, Clark, Caswell)Department of Pathology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt (Taha-Abdelaziz)U.S. Department of Agriculture, National Animal Disease Center, Ames, IA (Register)
| | - Mary Ellen Clark
- Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada (Taha-Abdelaziz, Bassel, Harness, Clark, Caswell)Department of Pathology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt (Taha-Abdelaziz)U.S. Department of Agriculture, National Animal Disease Center, Ames, IA (Register)
| | - Karen B Register
- Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada (Taha-Abdelaziz, Bassel, Harness, Clark, Caswell)Department of Pathology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt (Taha-Abdelaziz)U.S. Department of Agriculture, National Animal Disease Center, Ames, IA (Register)
| | - Jeff L Caswell
- Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada (Taha-Abdelaziz, Bassel, Harness, Clark, Caswell)Department of Pathology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt (Taha-Abdelaziz)U.S. Department of Agriculture, National Animal Disease Center, Ames, IA (Register)
| |
Collapse
|
14
|
|
15
|
El Khatib N, Ferroni A, Le Bourgeois M, Chedevergne F, Clairicia M, Avril H, Guiso N, Sermet-Gaudelus I. Persistent Bordetella bronchiseptica infection in a child with cystic fibrosis: Relationship to bacterial phenotype. J Cyst Fibros 2015; 14:E13-5. [PMID: 25900817 DOI: 10.1016/j.jcf.2015.03.014] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2015] [Revised: 03/24/2015] [Accepted: 03/24/2015] [Indexed: 10/23/2022]
Abstract
Bordetella bronchiseptica is an opportunistic bacteria infecting the respiratory tract of patients with cystic fibrosis. We present a case of B. bronchiseptica chronic pulmonary infection and documentation of some phenotypic attributes of the clinical isolates allowing the microorganism to induce progressive respiratory degradation and chronic sputum colonization. We recommend implementing adequate treatment aiming eradication from the first isolation of this bacterium. We advise for practices that minimize opportunities for zoonotic transmission of B. bronchiseptica from family pets.
Collapse
Affiliation(s)
- Nevine El Khatib
- Centre de Ressources et de Compétences de la Mucoviscidose, Service de Pneumologie et d'allergologie de l'Enfant, Hôpital Necker-Enfants malades, Paris, France
| | - Agnes Ferroni
- Laboratoire de Microbiologie, Hôpital Necker-Enfants malades, Paris, France
| | - Muriel Le Bourgeois
- Centre de Ressources et de Compétences de la Mucoviscidose, Service de Pneumologie et d'allergologie de l'Enfant, Hôpital Necker-Enfants malades, Paris, France
| | - Frederique Chedevergne
- Centre de Ressources et de Compétences de la Mucoviscidose, Service de Pneumologie et d'allergologie de l'Enfant, Hôpital Necker-Enfants malades, Paris, France
| | - Marlene Clairicia
- Centre de Ressources et de Compétences de la Mucoviscidose, Service de Pneumologie et d'allergologie de l'Enfant, Hôpital Necker-Enfants malades, Paris, France
| | - Helene Avril
- Centre de Ressources et de Compétences de la Mucoviscidose, Service de Pneumologie et d'allergologie de l'Enfant, Hôpital Necker-Enfants malades, Paris, France
| | - Nicole Guiso
- National Centre of Reference of Pertussis and other Bordetelloses, Institut Pasteur., Paris, France
| | - I Sermet-Gaudelus
- Centre de Ressources et de Compétences de la Mucoviscidose, Service de Pneumologie et d'allergologie de l'Enfant, Hôpital Necker-Enfants malades, Paris, France; Université Paris-Sorbonne, Paris, France; INSERM U 1151, Paris, France.
| |
Collapse
|
16
|
Draft Genome Assembly of Bordetella bronchiseptica ATCC 10580, a Historical Canine Clinical Isolate. GENOME ANNOUNCEMENTS 2014; 2:2/5/e00916-14. [PMID: 25237025 PMCID: PMC4172274 DOI: 10.1128/genomea.00916-14] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
We present the scaffolded genome of Bordetella bronchiseptica ATCC 10580, assembled into 98 contigs. This 5.1-Mb assembly (68.2% G+C content) contains 4,870 coding regions. The strain was originally isolated from canine lung tissue and is used in quality control testing.
Collapse
|
17
|
Comparative analyses of a cystic fibrosis isolate of Bordetella bronchiseptica reveal differences in important pathogenic phenotypes. Infect Immun 2014; 82:1627-37. [PMID: 24470470 DOI: 10.1128/iai.01453-13] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
Bordetella bronchiseptica is a Gram-negative bacterium that infects and causes disease in a wide variety of animals. B. bronchiseptica also infects humans, thereby demonstrating zoonotic transmission. An extensive characterization of human B. bronchiseptica isolates is needed to better understand the distinct genetic and phenotypic traits associated with these zoonotic transmission events. Using whole-genome transcriptome and CGH analysis, we report that a B. bronchiseptica cystic fibrosis isolate, T44625, contains a distinct genomic content of virulence-associated genes and differentially expresses these genes compared to the sequenced model laboratory strain RB50, a rabbit isolate. The differential gene expression pattern correlated with unique phenotypes exhibited by T44625, which included lower motility, increased aggregation, hyperbiofilm formation, and an increased in vitro capacity to adhere to respiratory epithelial cells. Using a mouse intranasal infection model, we found that although defective in establishing high bacterial burdens early during the infection process, T44625 persisted efficiently in the mouse nose. By documenting the unique genomic and phenotypic attributes of T44625, this report provides a blueprint for understanding the successful zoonotic potential of B. bronchiseptica and other zoonotic bacteria.
Collapse
|